Table 1.
Cancer Biomarker | Cancer Type | Reference |
---|---|---|
PSA | Prostate | [37] |
IgG | Prostate | [38] |
PAP, PSA | Prostate | [39] |
Peptide fragments | Colorectal | [40] |
MMP | Colorectal | [41] |
CEA, CA 19-9, CA A24-2 | Colorectal and pancreatic | [42] |
P53 gene | Colorectal | [43] |
CYFRA 21-1 | Lung | [44] |
CEA, CA 19-9, SCC antigen, NSE | Lung | [45] |
EVOM | Breast | [46] |
EGFR, HER2, transmembrane glycoproteins CD44 and CD24 | Breast | [47] |
Sialic acid | Breast and liver | [48] |
AFP | Liver | [49] |
CA 125, HE4 | Ovarian | [50] |
TRP-2, NY-ESO-1 melanoma Antigen | Melanoma | [51] |
Abbreviations: IgG—immunoglobulin G; PAP—prostatic acid phosphatase; MMP—matrix metalloproteinase; CA—cancer antigen; CYFRA—cytokeratin fragment; SCC—squamous cell carcinoma; EVOM—endogenous volatile organic metabolites; EGFR—epidermal growth factor receptor; HER—human epidermal growth factor receptor; SA—sialic acid; AFR—α-fetoprotein; HE—human epididymis protein; TRP—tyrosinase-related protein.